Why Are Drug Manufacturers Disregarding Clinical Trial Transparency Regulations?

A recent study found that most pharmaceutical companies do not meet rules demanding transparency in clinical trials. This lack of transparency is yet another point of contention surrounding pharma in the United States.

“In the latest look at clinical trial transparency, a new analysis found that only 26% of drug makers made results publicly available for all studies used to win approval for their medicines during a recent two-year period.” Read more here.

(Source: Ed Silverman, STAT News, 7/22/21)